The Role of Inflammatory Mediators in the Pathogenesis of Otitis Media and Sequelae

키워드

참고문헌 (280)

1. Juhn SK, "Determining otitis media severity from middle ear fluid analysis", Ann Otol Rhinol Laryngol Suppl, 163, pp.43~45 (1994)
2. Kock A, "Human keratinocytes are a source for tumor necrosis factor alpha:evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light", J Exp Med, 172(6), pp.1609~1614 (1990)
3. Kupper TS, "The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses", J Invest Dermatol, 94(6 Suppl), pp.146S~150S (1990)
4. Hansen ER, "Epidermal interleukin 1 alpha functional activity and interleukin 8immunoreactivity are increased in patients with cutaneous T-cell lymphoma", J Invest Dermatol, 97(5), pp.818~823 (1991)
5. Luger TA, "Cytokines and the skin", Curr Probl Dermatol, 19, pp.35~49 (1990)
6. Ghaheri BA, "Cochlear cytokine gene expression in murine chronic otitis media", Otolaryngol Head Neck Surg, 137(2), pp.332~337 (2007)
7. Seifert PS, "Complement activation after aortic endothelial injury", Semin Thromb Hemost, 12(4), pp.280~283 (1986)
8. Bernstein JM, "Complement activity in middle ear effusions", Clin Exp Immunol, 33(2), pp.340~346 (1978)
9. Meri S, "Complement in chronic secretory otitis media. C3 breakdown and C3 splitting activity", Arch Otolaryngol, 110(12), pp.774~778 (1984)
10. Ryan AF, "The effect of complement depletion on immunologically mediated middle ear effusion and inflammation", Clin Immunol Immunopathol, 40(3), pp.410~421 (1986)
11. Narkio-Makela M, "Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion", Clin Exp Immunol, 116(3), pp.401~409 (1999)
12. Leitao MF, "Complement factor I deficiency in a family with recurrent infections", Immunopharmacology, 38(1-2), pp.207~213 (1997)
13. Treves AJ, "Constitutive secretion of interleukin 1 by human monocytes", Eur J Immunol, 13(8), pp.647~651 (1983)
14. Strober W, "The interleukins", Pediatr Res, 24(5), pp.549~557 (1988)
15. Juhn SK, "The levels of IL-1 beta in human middle ear effusions", Acta Otolaryngol Suppl, 493, pp.37~42 (1992)
16. Matkovic S, "Comparison of cytokine levels in bilateral ear effusions in patients with otitis media secretoria", Otolaryngol Head Neck Surg, 137(3), pp.450~453 (2007)
17. Kunkel SL, "Manual of vascular mediators", pp.2~14 (1993), HP Publishing Company
18. Kunkel SL, "Cellular and molecular aspects of granulomatous inflammation", Am J Respir Cell Mol Biol, 1(6), pp.439~447 (1989)
19. Chensue SW, "Biologic and immunohistochemical analysis of macrophage interleukin-1 alpha, - 1 beta, and tumor necrosis factor production during the peritoneal exudative response", J Leukoc Biol, 46(6), pp.529~537 (1989)
20. Gery I, "Potentiation of the T-lymphocyte response to mitogens. II. The cellular source of potentiating mediator(s)", J Exp Med, 136(1), pp.143~155 (1972)
21. Staren ED, "Overview of biological response modifiers", Semin Surg Oncol, 5(6), pp.379~384 (1989)
22. Gowen M, "Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro", J Immunol, 136(7), pp.2478~2482 (1986)
23. Ghezzi P, "IL-1 induces IL-1. III. Specific inhibition of IL-1 production by IFN-gamma", J Immunol, 140(12), pp.4238~4244 (1988)
24. Nawroth PP, "Tumor necrosis factor", cachectin interacts with endothelial cell receptors to induce release of interleukin 1, 1986, pp.163(6), 1363~1375
25. Kilian PL, "Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells", J Immunol, 136(12), pp.4509~4514 (1986)
26. Kohase M, "A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1", Mol Cell Biol, 7(1), pp.273~280 (1987)
27. Matsushima K, "Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor", J Exp Med, 167(6), pp.1883~1893 (1988)
28. Cruse JM, "Atlas of immunology", pp.285~319 (2004), CRC Press LLC
29. Dinarello CA, "Biology of interleukin 1", FASEB J, 2(2), pp.108~115 (1988)
30. Conlon PJ, "Localization of human mononuclear cell interleukin 1", J Immunol, 139(1), pp.98~102 (1987)
31. Dinarello CA, "Interleukin-1", Dig Dis Sci, 33(3 Suppl), pp.25S~35S (1988)
32. Kunkel SL, "Arachidonic acid metabolites regulate interleukin-1 production", Biochem Biophys Res Commun, 128(2), pp.892~897 (1985)
33. Durum SK, "Interleukin 1: an immunological perspective", Annu Rev Immunol, 3, pp.263~287 (1985)
34. Koltai M, "Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I)", Drugs, 42(1), pp.9~29 (1991)
35. Arend WP, "IL-1 beta production in cultured human monocytes is regulated at multiple levels", J Immunol, 143(1), pp.118~126 (1989)
36. Goeken NE, "Monocyte suppressor factor is plasminogen activator inhibitor inhibition of membrane bound but not soluble IL-1", J Immunol, 143(2), pp.603~608 (1989)
37. Springer TA, "Adhesion receptors of the immune system", Nature, 346(6283), pp.425~434 (1990)
38. Kim SJ, "Interleukin-1beta upregulates Na+-K+-2Cl- cotransporter in human middle ear epithelia", J Cell Biochem, 101(3), pp.576~586 (2007)
39. Choi JY, "Interleukin-1beta suppresses epithelial sodium channel beta-subunit expression and ENaC-dependent fluid absorption in human middle ear epithelial cells", Eur J Pharmacol, 567(1-2), pp.19~25 (2007)
40. Watanabe T, "Role of interleukin-1beta in a murine model of otitis media with effusion", Ann Otol Rhinol Laryngol, 110(6), pp.574~580 (2001)
41. Sato K, "Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model", Infect Immun, 67(4), pp.1943~1946 (1999)
42. Sato K, "Course of IL-1beta, IL-6, IL-8, and TNF-alpha in the middle ear fluid of the guinea pig otitis media model induced by nonviable Haemophilus influenzae", Ann Otol Rhinol Laryngol, 108(6), pp.559~563 (1999)
43. Barzilai A, "Dynamics of interleukin-1 production in middle ear fluid during acute otitis media treated with antibiotics", Infection, 27(3), pp.173~176 (1999)
44. Barzilai A, "Cytokine analysis of middle ear effusions during acute otitis media: significant reduction in tumor necrosis factor alpha concentrations correlates with bacterial eradication", Pediatr Infect Dis J, 18(3), pp.301~303 (1999)
45. Yellon RF, "Characterization of cytokines present in middle ear effusions", Laryngoscope, 101(2), pp.165~169 (1991)
46. Ondrey FG, "Early-response cytokine expression in adult middle ear effusions", Otolaryngol Head Neck Surg, 119(4), pp.342~345 (1998)
47. Gaffen SL, "Expression of the immunoglobulin J chain in a murine B lymphoma is driven by autocrine production of interleukin 2", Cytokine, 8(7), pp.513~524 (1996)
48. Melhus A, "Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat", Infect Immun, 68(7), pp.4024~4031 (2000)
49. Jang CH, "Characterization of cytokines present in pediatric otitis media with effusion: comparison of allergy positive and negative", Int J Pediatr Otorhinolaryngol, 66(1), pp.37~40 (2002)
50. Smirnova MG, "The immunoregulatory and allergy-associated cytokines in the aetiology of the otitis media with effusion", Mediators Inflamm, 13(2), pp.75~88 (2004)
51. Pennica D, "Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin", Nature, 312(5996), pp.724~729 (1984)
52. Gray PW, "Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity", Nature, 312(5996), pp.721~724 (1984)
53. Nedwin GE, "Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization", Nucleic Acids Res, 13(17), pp.6361~6373 (1985)
54. DeMaria TF, "Tumor necrosis factor during experimental lipopolysaccharide-induced otitis media", Laryngoscope, 107(3), pp.369~372 (1997)
55. Dinarello CA, "Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1", J Exp Med, 163(6), pp.1433~1450 (1986)
56. Ikejima T, "Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits", J Infect Dis, 162(1), pp.215~223 (1990)
57. Waage A, "Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha", cachectin in mice, 1988, pp.167(6), 1987~1992
58. Jung TT, "Prostaglandins, leukotrienes, and other arachidonic acid metabolites in the pathogenesis of otitis media", Laryngoscope, 98(9), pp.980~993 (1988)
59. Nonomura N, "Early biochemical events in pneumococcal otitis media: arachidonic acid metabolites in middle ear fluid", Ann Otol Rhinol Laryngol, 100(5 Pt 1), pp.385~388 (1991)
60. Norris JG, "Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha", J Immunol, 152(2), pp.841~850 (1994)
61. Maxwell KS, "Interleukin-8 expression in otitis media", Laryngoscope, 104(8 Pt 1), pp.989~995 (1994)
62. Lane TA, "Protein kinase C inhibitors block the enhanced expression of intercellular adhesion molecule-1on endothelial cells activated by interleukin-1, lipopolysaccharide and tumor necrosis factor", Biochem Biophys Res Commun, 172(3), pp.1273~1281 (1990)
63. Mattila P, "TNF alpha-induced expression of endothelial adhesion molecules, ICAM-1 and VCAM-1, is linked to protein kinase C activation", Scand J Immunol, 36(2), pp.159~165 (1992)
64. Ophir D, "Tumor necrosis factor in middle ear effusions", Arch Otolaryngol Head Neck Surg, 114(11), pp.1256~1258 (1988)
65. Ball SS, "Role of tumor necrosis factor and interleukin-1 in endotoxin-induced middle ear effusions", Ann Otol Rhinol Laryngol, 106(8), pp.633~639 (1997)
66. Maxwell K, "Cytokine expression in otitis media with effusion. Tumor necrosis factor soluble receptor", Arch Otolaryngol Head Neck Surg, 123(9), pp.984~988 (1997)
67. Xie M, "Interleukin-6 and tumor necrosis factor-alpha in middle ear effusions", Zhonghua Er Bi Yan Hou Ke Za Zhi, 32(5), pp.280~282 (1997)
68. Nell MJ, "Endotoxin and tumor necrosis factor-alpha in middle ear effusions in relation to upper airway infection", Laryngoscope, 109(11), pp.1815~1819 (1999)
69. Bikhazi P, "Expression of immunoregulatory cytokines during acute and chronic middle ear immune response", Laryngoscope, 105(6), pp.629~634 (1995)
70. Sanderson CJ, "The cytokine handbook", pp.175~195 (1998), Academic Press Limited
71. Sonoda E, "Differential regulation of IgA production by TGF-beta and IL-5: TGF-beta induces surface IgA-positive cells bearing IL-5 receptor, whereas IL-5 promotes their survival and maturation into IgAsecreting cells", Cell Immunol, 140(1), pp.158~172 (1992)
72. Iino Y, "Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media", Clin Exp Allergy, 35(10), pp.1370~1376 (2005)
73. Smirnova MG, "Evidence of T-helper cell 2cytokine regulation of chronic otitis media with effusion", Acta Otolaryngol, 125(10), pp.1043~1050 (2005)
74. Perkins C, "IL-4 induces IL-13-independent allergic airway inflammation", J Allergy Clin Immunol, 118(2), pp.410~419 (2006)
75. Nutku E, "Ligation of Siglec-8:a selective mechanism for induction of human eosinophil apoptosis", Blood, 101(12), pp.5014~5020 (2003)
76. Heinrich PC, "Interleukin-6 and the acute phase response", Biochem J, 265(3), pp.621~636 (1990)
77. Hirano T., "The cytokine handbook", pp.198~228 (1998), Academic Press Limited
78. Kishimoto T., "The biology of interleukin-6", Blood, 74(1), pp.1~10 (1989)
79. Principi N, "C-reactive protein in acute otitis media", Pediatr Infect Dis, 5(5), pp.525~527 (1986)
80. Yellon RF, "Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions", Arch Otolaryngol Head Neck Surg, 121(8), pp.865~869 (1995)
81. Kerschner JE, "Middle ear epithelial mucin production in response to interleukin-6 exposure in vitro", Cytokine, 26(1), pp.30~36 (2004)
82. Heikkinen T, "Serum interleukin-6 in bacterial and nonbacterial acute otitis media", Pediatrics, 102(2 Pt 1), pp.296~299 (1998)
83. Fogle-Ansson M, "Otomicroscopic findings and systemic interleukin-6 levels in relation to etiologic agent during experimental acute otitis media", APMIS, 114(4), pp.285~291 (2006)
84. Fiorentino DF, "IL-10 inhibits cytokine production by activated macrophages", J Immunol, 147(11), pp.3815~3822 (1991)
85. Hebda PA, "Cytokine profiles in a rat model of otitis media with effusion caused by eustachian tube obstruction with and without Streptococcus pneumoniae infection", Laryngoscope, 112(9), pp.1657~1662 (2002)
86. Cooter MS, "Transforming growth factor-beta expression in otitis media with effusion", Laryngoscope, 108(7), pp.1066~1070 (1998)
87. Somers T, "Growth factors in tympanic membrane perforations", Am J Otol, 19(4), pp.428~434 (1998)
88. Wang KS, "Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4", Blood, 95(10), pp.3183~3190 (2000)
89. Oppenheim JJ, "Properties of the novel proinflammatory supergene “intercrine” cytokine family", Annu Rev Immunol, 9, pp.617~648 (1991)
90. Schroder JM, "The neutrophil-activating peptide 1", interleukin 8, a novel neutrophil chemotactic cytokine, 1992, pp.40(1), 23~31
91. Baggiolini M, "Inflammation:Basic principles and clinical correlates", pp.247~263 (1992), Raven Press
92. Strieter RM, "Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta", Science, 243(4897), pp.1467~1469 (1989)
93. Baggiolini M, "Neutrophil-activating peptide-1", interleukin 8, a novel cytokine that activates neutrophils, 1989, pp.84(4), 1045~1049
94. ), "Am J Respir Cell Mol Biol", 1990, 479~486
95. Huber AR, "Regulation of transendothelial neutrophil migration by endogenous interleukin-8", Science, 254(5028), pp.99~102 (1991)
96. Zachariae CO, "Human cytokines", pp.181~195 (1992), Blackwell Scientific Publications
97. Takeuchi K, "Interleukin-8 gene expression in middle ear effusions", Ann Otol Rhinol Laryngol, 103(5 Pt 1), pp.404~407 (1994)
98. Johnson M, "Murine model of interleukin-8-induced otitis media", Laryngoscope, 107(10), pp.1405~1408 (1997)
99. Hotomi M, "Interleukin-8 in otitis media with effusion", Acta Otolaryngol, 114(4), pp.406~409 (1994)
100. Leibovitz E, "Interleukin 8 in middle ear fluid during acute otitis media: correlation with aetiology and bacterial eradication", Arch Dis Child, 82(2), pp.165~168 (2000)
101. Chonmaitree T, "Role of leukotriene B4 and interleukin-8 in acute bacterial and viral otitis media", Ann Otol Rhinol Laryngol, 105(12), pp.968~974 (1996)
102. Storgaard M, "Interleukin-8 and chemotactic activity of middle ear effusions", J Infect Dis, 175(2), pp.474~477 (1997)
103. Nassif PS, "Interleukin-8 concentration predicts the neutrophil count in middle ear effusion", Laryngoscope, 107(9), pp.1223~1227 (1997)
104. Smirnova MG, "In vitro study of IL-8 and goblet cells: possible role of IL-8 in the aetiology of otitis media with effusion", Acta Otolaryngol, 122(2), pp.146~152 (2002)
105. Valente AJ, "Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture", Biochemistry, 27(11), pp.4162~4168 (1988)
106. Carr MW, "Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant", Proc Natl Acad Sci U S A, 91(9), pp.3652~3656 (1994)
107. Gunn MD, "Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation", J Immunol, 158(1), pp.376~383 (1997)
108. Jiang Y, "Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes", J Immunol, 148(8), pp.2423~2428 (1992)
109. Vaddi K, "Regulation of monocyte integrin expression by beta-family chemokines", J Immunol, 153(10), pp.4721~4732 (1994)
110. Rollins BJ, "Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease", Mol Med Today, 2(5), pp.198~204 (1996)
111. Patel JA, "Influence of viral infection on middle ear chemokine response in acute otitis media", Abstracts of the sixth international symposium on recent advances in otitis media, pp.178~179 (1995)
112. Baggiolini M, "CC chemokines in allergic inflammation", Immunol Today, 15(3), pp.127~133 (1994)
113. Schall TJ, "Chemokines, leukocyte trafficking, and inflammation", Curr Opin Immunol, 6(6), pp.865~873 (1994)
114. Schousboe LP, "RANTES in otitis media with effusion: presence, role and correlation with cytokines and microbiology", APMIS, 109(6), pp.441~446 (2001)
115. Jang CH, "Demonstration of RANTES and eosinophilic cataionic protein in otitis media with effusion with allergy", Int J Pediatr Otorhinolaryngol, 67(5), pp.531~533 (2003)
116. Ebmeyer J, "Role of mast cells in otitis media", J Allergy Clin Immunol, 116(5), pp.1129~1135 (2005)
117. Dennis RG, "Action of inflammatory mediators on middle ear mucosa. A method for measuring permeability and swelling", Arch Otolaryngol, 102(7), pp.420~424 (1976)
118. Boisvert P, "Histamine-induced middle ear effusion and mucosal histopathology in the guinea pig", Ann Otol Rhinol Laryngol, 94(2 Pt 1), pp.212~216 (1985)
119. Goldie P, "Middle ear effusion induced by various inflammatory mediators and neuropeptides. An experimental study in the rat", Acta Otolaryngol, 108(3-4), pp.246~252 (1989)
120. Nakata J, "Experimental otitis media with effusion induced by middle ear effusion", Laryngoscope, 102(9), pp.1037~1042 (1992)
121. Skoner DP, "Inflammatory mediators in chronic otitis media with effusion", Arch Otolaryngol Head Neck Surg, 114(10), pp.1131~1133 (1988)
122. Berger G, "Mast cells in human middle ear mucosa in health and in disease", J Otolaryngol, 13(6), pp.370~374 (1984)
123. Esaki Y, "Histamine-induced mucociliary dysfunction and otitis media with effusion", Acta Otolaryngol Suppl, 486, pp.116~134 (1991)
124. Minami T, "Effects of various inflammatory mediators on eustachian tube patency", Acta Otolaryngol, 112(4), pp.680~685 (1992)
125. Minami T, "Regional blood flow volume in the eustachian tube", Acta Otolaryngol Suppl, 500, pp.80~83 (1993)
126. Downs BW, "Action of histamine on eustachian tube function", Otolaryngol Head Neck Surg, 124(4), pp.414~420 (2001)
127. Collins MP, "Adenoid histamine and its possible relationship to secretory otitis media", J Laryngol Otol, 99(7), pp.685~691 (1985)
128. Berger G, "Possible role of adenoid mast cells in the pathogenesis of secretory otitis media", Ann Otol Rhinol Laryngol, 103(8 Pt 1), pp.632~635 (1994)
129. Berger G, "Histamine levels in middle ear effusions", Acta Otolaryngol, 98(5-6), pp.385~390 (1984)
130. Connolly DT, "Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis", J Clin Invest, 84(5), pp.1470~1478 (1989)
131. Kim TH, "Effect of recombinant vascular endothelial growth factor on experimental otitis media with effusion", Acta Otolaryngol, 125(3), pp.256~259 (2005)
132. Jung HH, "Expression of vascular endothelial growth factor in otitis media", Acta Otolaryngol, 119(7), pp.801~808 (1999)
133. Hamaguchi Y, "Plasma component of middle ear effusion evaluated by prekallikrein level", ORL J Otorhinolaryngol Relat Spec, 47(3), pp.145~150 (1985)
134. Hamaguchi Y, "Significance of kallikrein-kinin system in otitis media with effusion", Ann Otol Rhinol Laryngol Suppl, 124, pp.5~8 (1986)
135. Prescott SM, "Platelet-activating factor", J Biol Chem, 265(29), pp.17381~17384 (1990)
136. Tessner TG, "Stimulation of platelet-activating factor synthesis by a nonmetabolizable bioactive analog of platelet-activating factor and influence of arachidonic acid metabolites", J Biol Chem, 264(9), pp.4794~4799 (1989)
137. McIntyre TM, "Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils", Proc Natl Acad Sci USA, 83(7), pp.2204~2208 (1986)
138. Nakashima S, "Mechanism of arachidonic acid liberation in platelet-activating factor-stimulated human polymorphonuclear neutrophils", J Immunol, 143(4), pp.1295~1302 (1989)
139. Hayashi H, "Activation of guinea pig peritoneal macrophages by platelet activating factor (PAF) and its agonists", J Biochem, 97(6), pp.1737~1745 (1985)
140. Tsuji H, "The presence of platelet-activating factor-acetylhydrolase in human middle ear effusions", ORL J Otorhinolaryngol Relat Spec, 60(1), pp.25~29 (1998)
141. Jung TT, "Effect of inhibitors of leukotriene and", or platelet activating factor on killed H. influenzae induced experimental otitis media with effusion, 2004, pp.68(1), 57~63
142. Rhee CK, "Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs", Ann Otol Rhinol Laryngol, 108(5), pp.453~458 (1999)
143. Jung TT, "Profile of arachidonic acid metabolites and platelet activating factor in human middle ear effusion", Recent advances in otitis media, Proceedings of the fifth international symposium, pp.415~419 (1993), Decker Periodicals
144. Jung TT, "Effect of prostaglandin, leukotriene, and arachidonic acid on experimental otitis media with effusion in chinchillas", Ann Otol Rhinol Laryngol Suppl, 148, pp.28~32 (1990)
145. Goldie P, "Arachidonic acid metabolites in experimental otitis media and effects of anti-inflammatory drugs", Ann Otol Rhinol Laryngol, 102(12), pp.954~960 (1993)
146. Diven WF, "Treatment of experimental acute otitis media with ibuprofen and ampicillin", Int J Pediatr Otorhinolaryngol, 33(2), pp.127~139 (1995)
147. Clark MA, "Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells", Biochem J, 250(1), pp.125~132 (1988)
148. Clark MA, "The role of phospholipase A2 activating protein (PLAP) in regulating prostanoid production in smooth muscle and endothelial cells following leukotriene D4 treatment", Adv Exp Med Biol, 275, pp.125~144 (1990)
149. Ganbo T, "Inhibition of mucociliary clearance of the eustachian tube by leukotrienes C4 and D4", Ann Otol Rhinol Laryngol, 104(3), pp.231~236 (1995)
150. Piper PJ, "Formation and actions of leukotrienes", Physiol Rev, 64(2), pp.744~761 (1984)
151. Swarts JD, "Eicosanoid synthesis and inactivation in healthy and infected chinchilla middle ears", Acta Otolaryngol, 117(6), pp.845~850 (1997)
152. Tada N, "Experimental otitis media with effusion induced by leukotriene D4", Auris Nasus Larynx, 29(2), pp.127~132 (2002)
153. Combs JT, "The effect of montelukast sodium on the duration of effusion of otitis media", Clin Pediatr (Phila), 43(6), pp.529~533 (2004)
154. Moncada S., "“Ottorino Rossi” Award 1997. The biology of nitric oxide", Funct Neurol, 12(3-4), pp.134~140 (1997)
155. Rose AS, "Nitric oxide mediates mucin secretion in endotoxin-induced otitis media with effusion", Otolaryngol Head Neck Surg, 116(3), pp.308~316 (1997)
156. Li W, "Expression of inducible nitric oxide synthase (iNOS) in middle ear epithelial cells by IL-1beta and TNF-alpha", Int J Pediatr Otorhinolaryngol, 55(2), pp.91~98 (2000)
157. Watanabe K, "Expression of inducible nitric oxide synthase in the cochlea following immune response in the endolymphatic sac of guinea pigs", ORL J Otorhinolaryngol Relat Spec, 63(3), pp.155~159 (2001)
158. Wright DT, "Oxidant stress stimulates mucin secretion and PLC in airway epithelium via a nitric oxide-dependent mechanism", Am J Physiol, 271(5 Pt 1), pp.L854~L861 (1996)
159. Fischer BM, "Tumor necrosis factor-alpha (TNF-alpha) stimulates mucin secretion and gene expression in airway epithelium in vitro", Chest, 107(3 Suppl), pp.133S~135S (1995)
160. Adler KB, "Hypersecretion of mucin in response to inflammatory mediators by guinea pig tracheal epithelial cells in vitro is blocked by inhibition of nitric oxide synthase", Am J Respir Cell Mol Biol, 13(5), pp.526~530 (1995)
161. Chole RA, "Inhibition of nitric oxide synthase blocks osteoclastic bone resorption in adaptive bone modeling", Acta Otolaryngol, 118(5), pp.705~711 (1998)
162. Jeon EJ, "Effect of nitric oxide and peroxynitrite on mucociliary transport function of experimental otitis media", Otolaryngol Head Neck Surg, 134(1), pp.126~131 (2006)
163. Takoudes TG, "Evidence of oxygen free radical damage in human otitis media", Otolaryngol Head Neck Surg, 120(5), pp.638~642 (1999)
164. Himi T, "Immunologic characteristics of cytokines in otitis media with effusion", Ann Otol Rhinol Laryngol Suppl, 157, pp.21~25 (1992)
165. Burchett SK, "Regulation of tumor necrosis factor", cachectin and IL-1secretion in human mononuclear phagocytes, 1988, pp.140(10), 3473~3481
166. Willett DN, "Relationship of endotoxin to tumor necrosis factor-alpha and interleukin-1 beta in children with otitis media with effusion", Ann Otol Rhinol Laryngol, 107(1), pp.28~33 (1998)
167. Rhee CK, "Experimental otitis media with effusion induced by platelet activating factor", Ann Otol Rhinol Laryngol, 102(8 Pt 1), pp.600~605 (1993)
168. Giebink GS, "The bacteriology and cytology of chronic otitis media with effusion", Pediatr Infect Dis, 1(2), pp.98~103 (1982)
169. Sipila P, "Inflammatory cells in mucoid effusion of secretory otitis media", Acta Otolaryngol, 94(5-6), pp.467~472 (1982)
170. Kamimura M, "Adhesion molecules in immune-mediated otitis media with effusion", Abstracts of the sixth international symposium on recent advances in otitis media, pp.193~195 (1995)
171. Kawana M, "Early inflammatory changes of the middle ear in Haemophilus influenzae- induced experimental otitis media", Recent advances in otitis media. Proceedings of the second extraordinary international symposium on recent advances in otitis media, pp.591~594 (1994), Kugler Publications
172. Ichimiya I, "Analysis of immunocompetent cells in the middle ear mucosa", Arch Otolaryngol Head Neck Surg, 116(3), pp.324~330 (1990)
173. Sipila P., "Aspects of biological potentials of mononuclear cells in middle ear effusions", Acta Otolaryngol Suppl, 414, pp.138~142 (1984)
174. Lim DJ, "Functional morphology of the lining membrane of the middle ear and Eustachian tube: an overview", Ann Otol Rhinol Laryngol, 83(Suppl 11), pp.5~26 (1974)
175. Alm PE, "The release of histamine from the pars flaccida mast cells one cause of otitis media with effusion?", Acta Otolaryngol, 94(5-6), pp.517~522 (1982)
176. Bernstein JM, "Characteristics of lymphocyte and macrophage reactivity in otitis media with effusion", Acta Otolaryngol Suppl, 414, pp.131~137 (1984)
177. Juhn SK, "Biochemical pathology of otitis media with effusion", Acta Otolaryngol Suppl, 414, pp.45~51 (1984)
178. Fujioka O, "Otitis media induced by a chemotactic factor in mongolian gerbils", Recent advances in otitis media. Proceedings of the second extraordinary international symposium on recent advances in otitis media, pp.187~191 (1994), Kugler Publications
179. Harada T, "Lysozyme levels in middle ear effusion and serum in otitis media", Arch Otolaryngol Head Neck Surg, 116(1), pp.54~56 (1990)
180. Juhn SK, "Biochemical and immunochemical characteristics of middle ear effusions in relation to bacteriological findings", Ann Otol Rhinol Laryngol Suppl, 89(3 Pt 2), pp.161~167 (1980)
181. Tos M., "Middle ear epithelia in chronic secretory otitis", Arch Otolaryngol, 106(10), pp.593~597 (1980)
182. Tos M., "The nose", pp.99~144 (1982), Elsevier
183. Tos M., "Anatomy and histology of the middle ear", Clin Rev Allergy, 2(4), pp.267~284 (1984)
184. Meyerhoff WL, "Pathology of chronic otitis media", Ann Otol Rhinol Laryngol, 87(6 Pt 1), pp.749~760 (1978)
185. Giebink GS, "Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla", Ann Otol Rhinol Laryngol, 96(2 Pt 1), pp.199~206 (1987)
186. Lowell SH, "Experimental otitis media following middle ear inoculation of nonviable Streptococcus pneumoniae", Ann Otol Rhinol Laryngol, 89(5 Pt 1), pp.479~482 (1980)
187. Rezes S, "Characterization of otitis media with effusion based on the ratio of albumin and immunoglobulin G concentrations in the effusion", Otol Neurotol, 28(5), pp.663~667 (2007)
188. Johnson MD, "Cytokines in experimental otitis media with effusion", Laryngoscope, 104(2), pp.191~196 (1994)
189. Gibson BW, "Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry", J Bacteriol, 175(9), pp.2702~2712 (1993)
190. Hitchcock PJ, "Lipopolysaccharide nomenclature--past, present, and future", J Bacteriol, 166(3), pp.699~705 (1986)
191. Iino Y, "Endotoxin in middle ear effusions tested with Limulus assay", Acta Otolaryngol, 100(1-2), pp.42~50 (1985)
192. Iino Y, "Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro", Ann Otol Rhinol Laryngol Suppl, 157, pp.16~20 (1992)
193. Waage A, "Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response", J Exp Med, 170(6), pp.1859~1867 (1989)
194. Van Snick J., "Interleukin-6: an overview", Annu Rev Immunol, 8, pp.253~278 (1990)
195. Le J, "Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities", Lab Invest, 56(3), pp.234~248 (1987)
196. Tong HH, "Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccharide htrB and rfaD mutants", Infect Immun, 69(6), pp.3678~3684 (2001)
197. Barrett TQ, "NF-kappaB in cultivated middle ear epithelium", Int J Pediatr Otorhinolaryngol, 67(8), pp.895~903 (2003)
198. Ovesen T, "Bacteria and endotoxin in middle ear fluid and the course of secretory otitis media", Clin Otolaryngol Allied Sci, 17(6), pp.531~534 (1992)
199. DeMaria TF, "Endotoxin in middle-ear effusions from patients with chronic otitis media with effusion", J Clin Microbiol, 20(1), pp.15~17 (1984)
200. Bernstein JM, "Detection of endotoxin in ear specimens from patients with chronic otitis media by means of the limulus amebocyte lysate test", Can J Microbiol, 26(4), pp.546~548 (1980)
201. Sakakura K, "Endotoxin and lysosomal protease activity in acute and chronic otitis media with effusion", Ann Otol Rhinol Laryngol, 99(5 Pt 1), pp.379~385 (1990)
202. Nonomura N, "Otitis media with effusion following inoculation of Haemophilus influenzae type b endotoxin", Arch Otorhinolaryngol, 243(1), pp.31~35 (1986)
203. Nonomura N, "Experimentally induced otitis media with effusion following inoculation with the outer cell wall of nontypable Haemophilus influenzae", Arch Otorhinolaryngol, 244(4), pp.253~257 (1987)
204. Ripley-Petzoldt ML, "The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media", J Infect Dis, 157(2), pp.245~255 (1988)
205. Miller MB, "Bacterial antigens and neutrophil granule proteins in middle ear effusions", Arch Otolaryngol Head Neck Surg, 116(3), pp.335~337 (1990)
206. Ohashi Y, "Experimental otitis media with effusion induced by lipopolysaccharide from Klebsiella pneumoniae. Mucociliary pathology of the eustachian tube", Acta Otolaryngol Suppl, 486, pp.105~115 (1991)
207. Maeda K, "Cytokine expression in experimental chronic otitis media with effusion in mice", Laryngoscope, 114(11), pp.1967~1972 (2004)
208. Bakaletz LO, "Effect of prostaglandin E2 and bacterial endotoxin on the rate of dye transport in the eustachian tube of the chinchilla", Ann Otol Rhinol Laryngol, 98(4 Pt 1), pp.278~282 (1989)
209. Ohashi Y, "Effects of human middle ear effusions on the mucociliary system of the tubotympanum in the guinea pig", Eur Arch Otorhinolaryngol, 252(1), pp.35~41 (1995)
210. Chung MH, "Moraxella (Branhamella)catarrhalis-induced experimental otitis media in the chinchilla", Acta Otolaryngol, 114(4), pp.415~422 (1994)
211. Sakakura Y, "Effects of endotoxin and neutrophil lysate on experimental otitis media with effusion in cats", Acta Otolaryngol Suppl, 483, pp.30~36 (1991)
212. Kawauchi H, "Endotoxin permeability through the round window", Acta Otolaryngol Suppl, 457, pp.100~115 (1989)
213. Kim CS, "Auditory brain stem response changes after application of endotoxin to the round window membrane in experimental otitis media", Otolaryngol Head Neck Surg, 112(4), pp.557~565 (1995)
214. Stenqvist M, "Electrophysiological effects of multiple instillation of Haemophilus influenzae type b endotoxin on the inner ear", Acta Otolaryngol, 117(3), pp.352~357 (1997)
215. Demaria TF, "Localization of nontypeable Haemophilus influenzae endotoxin in the middle and inner ear during experimental otitis media", Acta Otolaryngol, 119(5), pp.583~587 (1999)
216. Hatada EN, "NF-kappaB and the innate immune response", Curr Opin Immunol, 12(1), pp.52~58 (2000)
217. Baeuerle PA, "NF-kappa B: ten years after", Cell, 87(1), pp.13~20 (1996)
218. Ovesen T, "Nuclear factor-kappaB in middle ear epithelial cells: a methodological study using an ELISA", Acta Otolaryngol, 123(2), pp.306~309 (2003)
219. Stancovski I, "NF-kappaB activation: the I kappaB kinase revealed?", Cell, 91(3), pp.299~302 (1997)
220. Karin M., "How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex", Oncogene, 18(49), pp.6867~6874 (1999)
221. Shuto T, "Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha", beta-I kappa B alpha and MKK3, Proc Natl Acad Sci USA, pp.2001, 98(15)[DOI]
222. Watanabe T, "Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha", Proc Natl Acad Sci USA, 101(10), pp.3563~3568 (2004)
223. Aderem A, "Toll-like receptors in the induction of the innate immune response", Nature, 406(6797), pp.782~787 (2000)
224. Shuto T, "Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase", J Biol Chem, 277(19), pp.17263~17270 (2002)
225. Chen G, "TNF-R1 signaling: a beautiful pathway", Science, 296(5573), pp.1634~1635 (2002)
226. Shen H, "Synergistic induction of MUC5AC mucin by nontypeable Haemophilus influenzae and Streptococcus pneumoniae", Biochem Biophys Res Comm, 365(4), pp.795~800 (2008)
227. Ganbo T, "Mucosal dysfunction and damage induced by platelet activating factor (PAF)", Acta Otolaryngol, 110(5-6), pp.427~436 (1990)
228. Karja J, "Mucociliary function in children with secretory otitis media", Acta Otolaryngol, 95(5-6), pp.544~546 (1983)
229. Takeuchi K, "Prognosis of secretory otitis media in relation to viscoelasticity of effusions in children", Ann Otol Rhinol Laryngol, 98(6), pp.443~446 (1989)
230. Kubba H, "The aetiology of otitis media with effusion: a review", Clin Otol Allied Sci, 25(3), pp.181~194 (2001)
231. Carrie S, "Otitis media with effusion : components which contribute to the viscous properties", Acta Otolaryngol, 112(3), pp.504~511 (1992)
232. Takeuchi K, "Quantitation of tubotympanal mucociliary clearance in otitis media with effusion", Ann Otol Rhinol Laryngol, 99(3 Pt 1), pp.211~214 (1990)
233. Majima Y, "Rheological properties of middle ear effusions from children with otitis media with effusion", Ann Otol Rhinol Laryngol Suppl, 124, pp.1~4 (1986)
234. Inagaki M, "Ultrastructure of mucous blanket in otitis media with effusion", Ann Otol Rhinol Laryngol, 97(3 Pt 1), pp.313~317 (1988)
235. Pospiech L, "Soluble L-selectin and interleukin-8 in otitis media with effusion", Auris Nasus Larynx, 27(3), pp.213~217 (2000)
236. Chung MH, "Compositional difference in middle ear effusion: mucous versus serous", Laryngoscope, 112(1), pp.152~155 (2002)
237. Lin J, "Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-alpha: potential cause for mucoid otitis media", J Infect Dis, 182(3), pp.882~887 (2000)
238. Lin J, "Dexamethasone inhibits mucous glycoprotein secretion via a phospholipase A2-dependent mechanism in cultured chinchilla middle ear epithelial cells", Acta Otolaryngol, 117(3), pp.406~413 (1997)
239. Lin J, "Effects of platelet-activating factor (PAF) receptor blockage on mucous glycoprotein secretion in cultured chinchilla middle ear epithelium", Acta Otolaryngol, 116(1), pp.69~73 (1996)
240. Amesara R, "Effects of arachidonic acid metabolites on mucous glycoprotein production in middle ear epithelial cell culture", Recent advances in otitis media. Proceedings of the fifth international symposium, pp.411~413 (1993), Decker Periodicals
241. Kawano H, "Induction of mucous cell metaplasia by tumor necrosis factor alpha in rat middle ear: the pathological basis for mucin hyperproduction in mucoid otitis media", Ann Otol Rhinol Laryngol, 111(5 Pt 1), pp.415~422 (2002)
242. John EO, "Concentration of nitric oxide metabolites in middle ear effusion", Int J Pediatr Otorhinolaryngol, 60(1), pp.55~58 (2001)
243. Fischer BM, "Tumor necrosis factor-alpha stimulates mucin secretion and cyclic GMP production by guinea pig tracheal epithelial cells in vitro", Am J Respir Cell Mol Biol, 20(3), pp.413~422 (1999)
244. Ganbo T, "Effects of platelet activating factor on mucociliary clearance of the eustachian tube", Ann Otol Rhinol Laryngol, 105(2), pp.140~145 (1996)
245. Ohashi Y, "Soluble adhesion molecules in middle ear effusions from patients with chronic otitis media with effusion", Clin Otolaryngol Allied Sci, 23(3), pp.231~234 (1998)
246. Juhn SK, "Biochemical characteristics of middle ear effusions", Ann Otol Rhinol Laryngol, 85(2 Suppl 25 Pt 2), pp.110~116 (1976)
247. Jono H, "Transforming growth factor-beta -Smad signaling pathway cooperates with NFkappa B to mediate nontypeable Haemophilus influenzae-induced MUC2 mucin transcription", J Biol Chem, 277(47), pp.45547~45557 (2002)
248. Jono H, "Transforming growth factor-beta-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzae-induced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK", J Biol Chem, 278(30), pp.27811~27819 (2003)
249. Albino AP, "Cholesteatoma: a molecular and cellular puzzle", Am J Otol, 19(1), pp.7~19 (1998)
250. Ruedi L., "Pathogenesis and surgical treatment of the middle ear cholesteatoma", Acta Otolaryngol Suppl, 361, pp.1~45 (1979)
251. Friedmann L., "The comparative pathology of otitis media, experimental and human. II. The histopathology of experimental otitis of the guinea-pig with particular reference to experimental cholesteatoma", J Laryngol Otol, 69(9), pp.588~601 (1955)
252. Chung JW, "Different production of interleukin-1alpha, interleukin-1beta and interleukin-8 from cholesteatomatous and normal epithelium", Acta Otolaryngol, 118(3), pp.386~391 (1998)
253. Kato A, "Interleukin-6 and tumour necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the eustachian tube", Acta Otolaryngol Suppl, 538, pp.90~97 (1998)
254. Sudhoff H, "Angiogenesis and angiogenic growth factors in middle ear cholesteatoma", Am J Otol, 21(6), pp.793~798 (2000)
255. Yetiser S, "Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma", Otol Neurotol, 23(5), pp.647~652 (2002)
256. Myers EN, "Signal transduction pathway in human middle ear cholesteatoma", Otolaryngol Head Neck Surg, 120(6), pp.899~904 (1999)
257. Bujia J, "Aberrant expression of epidermal growth factor receptor in aural cholesteatoma", Laryngoscope, 103(3), pp.326~329 (1993)
258. Ergun S, "Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma", Am J Otol, 17(3), pp.393~396 (1996)
259. Bujia J, "Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma:an analysis of protein production and gene expression", Am J Otol, 17(2), pp.203~206 (1996)
260. Ottaviani F, "Cytokines and adhesion molecules in middle ear cholesteatoma. A role in epithelial growth?", Acta Otolaryngol, 119(4), pp.462~467 (1999)
261. Huang T, "Colony-stimulating factor in middle ear cholesteatoma", Am J Otolaryngol, 10(6), pp.393~398 (1989)
262. Albino AP, "Increased numbers of mast cells in human middle ear cholesteatomas: implications for treatment", Am J Otol, 19(3), pp.266~272 (1998)
263. Schilling V, "Immunologically activated cells in aural cholesteatoma", Am J Otolaryngol, 12(5), pp.249~253 (1991)
264. Yan SD, "The role of tumor necrosis factor-alpha in bone resorption of cholesteatoma", Am J Otolaryngol, 12(2), pp.83~89 (1991)
265. Yan SD, "Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro", Ann Otol Rhinol Laryngol, 100(2), pp.157~161 (1991)
266. Bertolini DR, "Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors", Nature, 319(6053), pp.516~518 (1986)
267. Dayer JM, "Cachectin", tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts, 1985, pp.162(6), 2163~2168
268. Saklatvala J., "Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage", Nature, 322(6079), pp.547~549 (1986)
269. Akimoto R, "Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process", ORL J Otorhinolaryngol Relat Spec, 62(5), pp.257~265 (2000)
270. Shiwa M, "Involvement of interleukin-1 in middle ear cholesteatoma", Am J Otolaryngol, 16(5), pp.319~324 (1995)
271. Kim CS, "Interleukin-1 alpha, interleukin-1 beta and interleukin-8 gene expression in human aural cholesteatomas", Acta Otolaryngol, 116(2), pp.302~306 (1996)
272. Ahn JM, "Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma", Otolaryngol Head Neck Surg, 103(4), pp.527~536 (1990)
273. Didierjean L, "Localization and characterization of the interleukin 1immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis", J Invest Dermatol, 92(6), pp.809~816 (1989)
274. Schonermark M, "Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas", Acta Otolaryngol, 116(3), pp.451~456 (1996)
275. Schonermark MP, "Expression pattern of the plasminogen activator-plasmin system in human cholesteatoma", Ann Otol Rhinol Laryngol, 108(3), pp.245~252 (1999)
276. Wilmoth JG, "Tympanic membrane metalloproteinase inflammatory response", Otolaryngol Head Neck Surg, 129(6), pp.647~654 (2003)
277. Juhn SK, "Effects of inflammatory mediators on middle ear pathology and on inner ear function", Ann N Y Acad Sci, 830, pp.130~142 (1997)
278. Goycoolea MV, "Permeability of the human round-window membrane to cationic ferritin", Arch Otolaryngol Head Neck Surg, 114(11), pp.1247~1251 (1988)
279. Juhn SK, "Nature of blood-labyrinth barrier in experimental conditions", Ann Otol Rhinol Laryngol, 90(2 Pt 1), pp.135~141 (1981)
280. Juhn SK, "Blood-labyrinth barrier and fluid dynamics of the inner ear", Int Tinnitus J, 7(2), pp.72~83 (2001)

관련 논문AI추천